Aster DM Healthcare : Q1 2024 Financial Quarterly Report : YoY Sales Down 68.84 %, QoQ Up 2.9 %

 

The comprehensive analytics outlining the performance and outlook of Aster DM Healthcare Limited”s stock. This analysis encompasses various metrics including stock performance, investor sentiment, market trends, future outlook, risk factors, investment opportunities, long-term strategy, dividend policy, analyst insights, and the overall risk-reward profile. These insights aim to provide investors with a holistic understanding of the company”s stock, enabling informed decision-making and strategic investment planning.

Today, we’re looking at Aster DM Healthcare Limited’s financial performance for the Q1(Jun 2024).Starting with the top line, the company reported a significant year-over-year sales decline of -68.84 %. However, it did see a marginal increase of 2.9 % from the previous quarter. Expenses ticked up slightly by 2.93 % quarter-on-quarter, aligning with the annual decline of -70.33 %. Operating profit, while down -57.72 % compared to last year, faced a quarter-on-quarter increase of 2.78 %, signaling a short-term expansion in margins.
The Operating Profit Margin (OPM) % echoes this narrative, showing resilience on an annual basis with an increase of 4.22 %, but a shrinkage of -0.02 % sequentially. Other income rose by 1094.12 % compared to the last quarter, despite an annual growth of 429.57 %. Interest expenses dropped significantly by -2.44 % from the previous quarter, yet the year-over-year decrease remains at a moderate -70.52 %. Depreciation costs climbed by 3.51 % quarter-on-quarter, yet on an annual scale, they experienced a reduction of -72.22 %. Profit before tax grew annually by 63.81 % but saw an increase from the preceding quarter by 65.92 %.
Tax expenses as a percentage of profits decreased slightly by -34.51 % compared to last year, with a more notable quarter-on-quarter decrease of -8.88 %. Net profit rose by 25855.67 % year-on-year but experienced a 237528.57 % expansion from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 103090 % but a quarterly rise of 21597.92 %. In summary, Aster DM Healthcare Limited’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.

In reviewing Aster DM Healthcare Limited’s 2024(Q1) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales experienced a decrease of -68.84 % year-on-year, however, there was a minor increase of 2.9 % from the previous quarter. Expenses decreased by -70.33 % compared to the previous year, with a 2.93 % increase quarter-on-quarter. Operating Profit dropped by -57.72 % annually, and saw a 2.78 % increase from the last quarter.
Net Profit showed yearly increase of 25855.67 %, and experienced a 237528.57 % increase from the previous quarter. Earnings Per Share (EPS) rose by 103090 % annually, however rose by 21597.92 % compared to the last quarter. In essence, while Aster DM Healthcare Limited exhibits strong annual growth indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.